| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2168 |
| Trial ID | NCT04049513 |
| Disease | B-Cell Non-Hodgkin's Lymphoma | Follicular Lymphoma | Mantle Cell Lymphoma | Primary Mediastinal B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | WZTL-002 |
| Generation | 3rd |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | ENABLE (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) |
| Year | 2019 |
| Country | New Zealand |
| Company sponsor | Malaghan Institute of Medical Research |
| Other ID(s) | WZTL002-1|U1111-1216-2053 |
| Cohort 1 | |||||||||||||
|
|||||||||||||